The therapeutic role of melatonin in cancer worthy of study
A systematic review of randomized controlled trials and meta-analysis found that melatonin reduced the risk of death at one year by 34%. Melatonin was also shown to have a beneficial effect on sleep patterns in patients. The researchers urge caution in interpreting the clinical usefulness of large doses of melatonin.
SourceMcMaster University, Department of Clinical Epidemiology·JournalJournal of Pineal Research·DateNov 22, 2005